Impact of Dermatologic Consultation on Cutaneous Immune-Related Adverse Events in Cancer Patients

Though cutaneous immune-related adverse events (cirAEs) are common among patients on immune checkpoint inhibitors, relationships between dermatology referral, cirAE treatment, and survival outcomes remain underexplored. In this study, we sought to comprehensively categorize cirAE patterns among all patients treated with immunotherapy at our institution, and to evaluate 1) the effect of dermatology referral on cirAE treatment, and 2) the impact of cirAE treatment on survival.